In this episode, Dr. Flavio Rezende explores the current state of affairs for retinal implants in Canada and worldwide, highlighting some of the benefits and limitations of the technology.
Dr. Rezende further provides an overview of gene therapy for inherited retinal dystrophies, explaining why such treatments seem to advance slowly and how the recent pandemic and improved access to genetic testing may accelerate the development of additional sight-saving ocular gene therapies.